Pisa Syndrome secondary to rivastigmine: a case report

被引：0

作者：

Leelavathi, M. ^{[1
]}

Rosdinom, R. ^{[2
]}

Suguna, M. ^{[3
]}

机构：

[1] Univ Kebangsaan Malaysia, Med Ctr, Fac Med, Dept Family Med, Kuala Lumpur 56000, Malaysia

[2] Univ Kebangsaan Malaysia, Med Ctr, Dept Psychiat, Kuala Lumpur 56000, Malaysia

[3] Selangor Med Ctr, Dept Internal Med, Shah Alam, Malaysia

来源：

CLINICA TERAPEUTICA | 2012年 / 163卷 / 01期

关键词：

cholinergic drug; Pisa syndrome; pleurothotonus; rivastigmine; CHOLINESTERASE INHIBITOR; PARKINSONS-DISEASE;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Pisa syndrome or pleurothotonus is the persistent flexion of the body and head to one side giving the appearance of the leaning tower of Pisa. It is most commonly caused by typical and atypical antipsychotic drugs. We report a case of Pisa Syndrome caused by prolonged use of high dose cholinesterase inhibitor, rivastigmine. Symptoms subsided when rivastigmine was withdrawn and did not reappear when a different cholinesterase inhibitor, donepezil was introduced. Physicians should be aware of Pisa syndrome and should alert patient of this possibility when starting and stepping up medications. The purpose of reporting this case is to create awareness among general practitioners as it is a reversible condition which responds to removal of the offending drug. Clin Ter 2012; 163(1):31-32

引用

页码：31 / 32

页数：2

共 10 条

[1] Reversible pisa syndrome in Parkinson's disease during treatment with pergolide - A case report [J].

Cannas, A ;

Solla, P ;

Floris, G ;

Borghero, G ;

Tacconi, P ;

Spissu, A .

CLINICAL NEUROPHARMACOLOGY, 2005, 28 (05) :252-252

[2] PISA SYNDROME INDUCED BY RAPID INCREASE AND HIGH DOSAGE OF RISPERIDONE [J].

Cordeiro, Quirino ;

Zung, Stevin ;

Vallada, Homero .

ARQUIVOS DE NEURO-PSIQUIATRIA, 2008, 66 (04) :896-897

[3] Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: Case report [J].

Cossu, G ;

Melis, M ;

Melis, G ;

Maccioni, E ;

Putzu, V ;

Catte, G ;

Putzu, PF .

MOVEMENT DISORDERS, 2004, 19 (10) :1243-1244

[4] Relation between cholinesterase inhibitor and Pisa syndrome [J].

Kwak, YT ;

Han, IW ;

Baik, J ;

Koo, MS .

LANCET, 2000, 355 (9222) :2222-2222

[5]

Stubner S, 2000, J Clin Psychiatry, V61, P569

[6] Drug-induced Pisa syndrome (pleurothotonus) - Epidemiology and management [J].

Suzuki, T ;

Matsuzaka, H .

CNS DRUGS, 2002, 16 (03) :165-174

[7] Pisa syndrome in a cohort of Alzheimer's disease patients [J].

Vanacore, N ;

Suzzareddu, G ;

Maggini, M ;

Casula, A ;

Capelli, P ;

Raschetti, R .

ACTA NEUROLOGICA SCANDINAVICA, 2005, 111 (03) :199-201

[8] Cholinergic-dopaminergic imbalance in Pisa syndrome [J].

Villarejo, A ;

Camacho, A ;

García-Ramos, R ;

Moreno, T ;

Penas, M ;

Juntas, R ;

Ruiz, J .

CLINICAL NEUROPHARMACOLOGY, 2003, 26 (03) :119-121

[9]

Wang HQ, 2008, TAIWANESE J PSYCHIAT, V22, P154

[10] Lateral flexion in Parkinson's disease and Pisa syndrome [J].

Yokochi, Fusako .

JOURNAL OF NEUROLOGY, 2006, 253 (Suppl 7) :17-20

← 1 →